ClinConnect ClinConnect Logo
Search / Trial NCT06279468

Clinical Effectiveness of Intervertebral Disc Release in Treating Lenke 5 Adolescent Idiopathic Scoliosis

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Feb 25, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Intervertebral Disc Release Adolescent Idiopathic Scoliosis Derotation

ClinConnect Summary

This clinical trial is studying a new surgical technique called intervertebral disc release (IDR) to treat a specific type of scoliosis known as Lenke Type 5 adolescent idiopathic scoliosis (AIS). Scoliosis is a condition where the spine curves abnormally, and in this trial, researchers want to see if IDR can better correct the spine's rotation compared to a traditional method called Ponte osteotomy. The goal is to improve the patients' overall spinal alignment while minimizing complications like blood loss or longer hospital stays.

To participate in this study, individuals must be between the ages of 10 and 18 and have Lenke Type 5 AIS, without any previous spinal surgeries or certain other scoliosis conditions. Participants will be randomly assigned to receive either the IDR or the Ponte osteotomy. Throughout the trial, researchers will monitor how well each method corrects the spine's curvature, how much blood is lost during surgery, how long patients stay in the hospital, and any side effects that may occur. The insights gained from this study could help improve treatment options for young people with scoliosis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between the ages of 10 and 18
  • American Society of Anesthesiologists (ASA) physical statusclassification of I-II
  • Lenke 5 type adolescent idiopathic scoliosis
  • Exclusion Criteria:
  • A history of previous corrective surgery
  • With sharp, angulated short-segmental scoliosis
  • With congenital scoliosis requiring 3-column osteotomy

About Peking Union Medical College Hospital

Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.

Locations

Beijing, , China

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Qianyu Zhuang, Professor

Principal Investigator

Peking Union Medical College Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported